Meet the companies that live, breathe, and build the future. Together we’re transforming bold visions into viable, world-changing companies.
Automation / AI
Improving drug development through the use of artificial intelligence, computation, and biological automation.
Making manual labor safe and scalable with legged robots that go where humans go.
Pioneering new gene editing modalities using multi-kilobase RNA editing to treat undruggable diseases.
Protects applications at runtime with a hardware-grade security perimeter.
Automating life sciences, so that you can focus on the science, while robots do the work.
AI-driven RNA drug discovery
Powering high-fidelity remote collaboration during complex medical procedures.
We partner up with entrepreneurs to build the future. Let's Talk.
Using light to move data between chips delivering 1000x the bandwidth at 1/10th the power.
Managing heart disease through a data-driven virtual clinic powered by advanced cardiac monitoring.
Take control of your warehouse operations. Dynamic storage and retrieval platform that adapts to varying cubic dimensions and eliminates manual pick stations
Increasing mobile revenue with enterprise-grade deeplinks across all platforms.
Now part of Amazon, Canvas Technology provides unrivaled perception enabling robust autonomy in the most challenging environments.
Attacking the physics of memory-compute integration, delivering 10X compute efficiency for the same power envelope.
Decoupling storage and compute for zero-schema log management.
Making one-hour delivery possible and profitable with an on-demand micro-fulfillment platform.
Providing farmers with sustainable solutions to feed a growing world using AI and automation.
Unlocking subsurface potential of critical minerals using advanced geophysics
Transforming human antibodies into drugs.
Accelerating breakthroughs in neuroscience by imaging neural activity in vivo.
Harnessing the untapped power of lasso peptides to create an entirely new class of programmable medicines.
Empowering shippers, carriers and brokers to manage freight with unprecedented reliability using data and predictive analytics.
Transforming the way the world interacts with information through its integrated space-based communications and data network.
Transforming drug discovery into measurement-driven drug design.
Now part of Databricks, MosaicML trains and deploys generative AI models with your own data, in your own secure environment.
Encouraging safer driver behavior in real-time with in-vehicle AI technology.
Now part of Intel, Nervana is building a full-stack solution that is optimized from algorithms down to silicon to solve machine learning problems at scale.
Freeing human knowledge from the boundaries of compute with software defined hardware.
Revolutionizing medical imaging using new advances in quantum physics.
Tackling incurable disease with tailored cell therapy solutions.
Giving remote employees the meeting experience they deserve with IoT video conferencing hardware.
Redesigning shipping for the unique challenges of e-commerce.
Building the first useful quantum computer.
Sending life-saving data from any connected device to 9-1-1 and first responders.
Building humanity's multiplanetary future.
Powering the future of e-commerce order fulfillment with a solution that can automatically handle any item.
Creating the world’s first industrial-grade cognitive platform for robots.
Reimagining the warehouse for modern e-commerce.
Now part of Discord, Sentropy provides software solutions that protect online communities from hate and harassment using machine learning.
Building the most advanced flying AI to navigate the world with unparalleled autonomy.
Realizing the potential of gene therapy with the world’s first mRNA “programming language.”
Now part of DC Capital Partners, uAvionix protects the skies one drone at a time with a redefined transponder.
Fueling carbon-free flight.
Ushering in truly personalized medicine by sequencing a human genome for $100.
Manufacturing mission critical parts using industrial 3D metal printing. NYSE: VLD
Reversing Type II diabetes with a clinically proven treatment.